Langerhans cell histiocytosis epidemiology and demographics: Difference between revisions

	Langerhans cell histiocytosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Langerhans cell histiocytosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Langerhans cell histiocytosis epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Langerhans cell histiocytosis epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Langerhans cell histiocytosis epidemiology and demographics
on Langerhans cell histiocytosis epidemiology and demographics
Langerhans cell histiocytosis epidemiology and demographics in the news
Blogs on Langerhans cell histiocytosis epidemiology and demographics
Directions to Hospitals Treating Langerhans cell histiocytosis
Risk calculators and risk factors for Langerhans cell histiocytosis epidemiology and demographics

← Older edit Newer edit →

VisualWikitext

Revision as of 15:58, 21 December 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]

Overview

Epidemiology

Prevalence

Incidence

Age

Gender

Race

References

Template:WikiDoc Sources

@@ Line 1: / Line 1: @@
 __NOTOC__
 {{Langerhans cell histiocytosis}}
-{{CMG}}
+{{CMG}}; {{AE}} {{NM}}
-Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
 ==Overview==
-== Epidemiology ==
+==Epidemiology==
-LCH histiocytosis usually affects children of between 1 and 15 years old and peak incidence is between age 5 and 10.  Among children under the age of 10, yearly incidence is thought to be 1 in 200,000<ref>{{cite web |url=http://www.nlm.nih.gov/medlineplus/ency/article/000068.htm |title=MedlinePlus Medical Encyclopedia: Histiocytosis |accessdate=2007-05-10 |format= |work=}}</ref>; and in adults even more rare, in about 1 in 560,000.<ref>{{cite web|url=http://www.histiocytosis.ca/facts.html | title=Histiocytosis Association of Canada | accessdate=2007-05-16|format= |work=}}</ref> It has been reported in elderly but is vanishingly rare<ref>{{cite journal |author=Gerlach B, Stein A, Fischer R, Wozel G, Dittert D, Richter G |title=[Langerhans cell histiocytosis in the elderly] |language=German |journal=Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete |volume=49 |issue=1 |pages=23-30 |year=1998 |pmid=9522189}}</ref>. commoner in white race and boys are effected twice as often as girls.
+===Prevalence===
+===Incidence===
-LCH is usually sporadic and non-[[hereditary]] condition but familial clustering has been noted in limited number of cases. Hashimoto-Pritzker disease, a variant of Hand-Schüller-Christian disease, is a congenital self-healing form<ref>{{cite journal |author=Kapur P, Erickson C, Rakheja D, Carder K, Hoang M |title=Congenital self-healing reticulohistiocytosis (Hashimoto-Pritzker disease): ten-year experience at Dallas Children's Medical Center |journal=J. Am. Acad. Dermatol. |volume=56 |issue=2 |pages=290-4 |year=2007 |pmid=17224372}}</ref>.
+===Age===
+===Gender===
+===Race===
 ==References==
 {{Reflist|2}}

Langerhans cell histiocytosis epidemiology and demographics: Difference between revisions

Revision as of 15:58, 21 December 2015

Overview

Epidemiology

Prevalence

Incidence

Age

Gender

Race

References

Navigation menu

Search